logo

For the Inventor, By the Inventor

St. Louis, MO, United States of America

Susan A Gregory

This inventor holds 13 USPTO granted patents, primarily in Immunosuppressive Agents. Top assignees: G.d. Searle & Company, Pharmacia Corporation, Other. Active years: 1993-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susan A Gregory. Retrieved from https://idiyas.com/inventor/susan-a-gregory

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13

% Patents Active = 84.6

Average Co-Inventor Count = 3.4

ph-index = 7

Forward Citations = 333(Granted Patents)


Company Filing History:

goldMedal11 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal1 out of 220 
 
Pharmacia Corporation
 patents
bronzeMedal1 out of 834,708 
Other
 patents

Years Active: 1993-2006

Loading Chart...
Areas of Expertise:
Cyclooxygenase Inhibitors
Leukotriene Antagonists
Immunosuppressive Effects
Inflammation Treatment
Halogenated Compounds
Phenylacetonitrile
5-Lipoxygenase Inhibitors
Inflammation Disorders
13 patents (USPTO):Explore Patents
1. 7141599 - [object Object] (2006-11-28),
2. 7132441 - Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor (2006-11-07),
3. 6617345 - Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin (2003-09-09),
4. 6407140 - Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor (2002-06-18),
5. 6376528 - Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor (2002-04-23),
6. 6342510 - Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist (2002-01-29),
7. 6265439 - Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives (2001-07-24),
8. 6172096 - Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist (2001-01-09),
9. 6136839 - Treatment of inflammation and inflammation-related disorders with a (2000-10-24),
10. 5990148 - Treatment of inflammation and inflammation-related disorders with a (1999-11-23),
11. 5700816 - Treatment of inflammation and inflammation-related disorders with a (1997-12-23),
12. 5451604 - Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as (1995-09-19),
13. 5247119 - Phenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl (1993-09-21),

Title: Innovations and Contributions of Susan A Gregory

Introduction

Susan A Gregory is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of immunology and organ transplantation. With a total of 13 patents, her work has had a profound impact on medical treatments and therapies.

Latest Patents

Among her latest patents, one notable invention involves the treatment with a cyclooxygenase-2 inhibitor and a leukotriene B receptor antagonist. This treatment is described as being useful in reducing recipient rejection of transplanted organs and for the treatment of autoimmune diseases. Another significant patent focuses on the immunosuppressive effects of administering a combination of a cyclooxygenase-2 inhibitor, a 5-lipoxygenase inhibitor, and an immunosuppressive drug. This combination may be utilized to suppress the immune response associated with organ transplantation, graft versus host disease, and conditions with underlying autoimmune or inflammatory reactivities.

Career Highlights

Throughout her career, Susan has worked with notable companies, including G.D. Searle & Company. Her innovative approaches and research have positioned her as a leader in her field.

Collaborations

Susan has collaborated with esteemed colleagues such as Gary D Anderson and Peter C Isakson. These partnerships have further enhanced her research and contributions to medical science.

Conclusion

Susan A Gregory's work exemplifies the spirit of innovation in the medical field. Her patents and collaborations have paved the way for advancements in organ transplantation and autoimmune disease treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…